Nonpeptide somatostatin type 5 receptor agonists and uses thereof
AssigneeCrinetics Pharmaceuticals, Inc.
InventorsJian Zhao, Yunfei Zhu, Shimiao Wang, Mi Chen, Joseph Pontillo
Life of this patent
Estimating the term…
Abstract
Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
Claims4
A method of treating hyperinsulinism in a mammal, the method comprising administering a compound to the mammal in need thereof, wherein the compound is 4-[(3S)-3-amino-3-methylpyrrolidin-1-yl]-6-cyano-5-(3,5-difluorophenyl)-N-[(2S)-1,1, 1-trifluoropropan-2-yl] pyridine-3-carboxamide, or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.